Fresh lemongrass stalks on wood surface

Lemongrass Sleep Supplement: Citral Talks to Neurons, No One Measured Dreams

By Winifred Oduya · Edited by Gus Feld

Listen · Winifred Oduya reads this piece · 2:00

The lemongrass sleep supplement aisle rests its case on one fact: citral, the primary compound in lemongrass essential oil, binds to GABA receptors in neurons. GABA receptors are the target of sedatives, anxiolytics, and every pharmaceutical that claims to help you sleep. Therefore lemongrass helps you sleep. That is the argument. It skips a step.

The step it skips: did anyone measure whether it actually makes people sleep?

Not sleep architecture. Not slow-wave depth. Not REM latency, wake time, or how you feel the next morning. The evidence stops at the receptor binding and the marketing picks up from there, like selling a key because it fits a lock without checking if the lock is attached to a door. Or if the door leads anywhere. Or if you even own the building.

What Citral Does to a Neuron Is Not What Lemongrass Does to Your Tuesday Night

Citral is real. It is a monoterpene aldehyde found in lemongrass, lemon balm, lemon myrtle, and about forty other plants that smell vaguely of furniture polish. In isolated neuron studies, citral shows affinity for GABA-A receptors, the same sites benzodiazepines bind to. A 2025 review on lemon balm, which also contains citral, lists anxiolytic and neuroprotective properties among its bioactive effects. Anxiolytic means it may reduce anxiety. It does not mean it puts you to sleep. Calm and unconscious are related the way cousins are related: technically family, would not recognize each other at the reunion.

Also, furniture polish does not help you sleep, despite the shared smell.

The word you see everywhere in lemongrass essential oil relaxation marketing is supports. Supports sleep. Supports calm. Supports relaxation. Supports. Like a folding chair. Nobody says what it is holding up, and if you ask for details the sentence folds in on itself and traps your finger.

A 2023 scoping review examined seventy studies on essential oils and the nervous system over a ten-year period. It reported antistress, antianxiety, analgesic, and cognitive effects. Sleep disorders appeared on the list of measured outcomes. Lavender was tested for sleep. Chamomile was tested. Bergamot, valerian, sandalwood. Lemongrass was mentioned for antimicrobial and anti-inflammatory properties, not sleep. If this were a CV, you would ask what the candidate has been doing since the receptor binding study, and why they keep bringing up that one project from grad school.

Lemongrass oil droplets in laboratory dish

The Aromatherapy Trials Tested Everything Except the Thing on the Label

A 2012 systematic review on aromatherapy in cancer care found short-term improvements in anxiety, depression, and sleep quality, lasting up to two weeks after treatment. The oils tested were lavender, chamomile, and tea tree. The delivery method was massage. Lemongrass did not appear. That review is now cited in marketing for natural sleep aid products, as if proximity on a list were the same as being tested. As if standing near a champion makes you one.

This is the gap. Citral binds a receptor tied to sedation. Lemongrass contains citral. Therefore lemongrass is a sleep aid. The missing middle: did anyone give lemongrass to a person, measure their sleep with polysomnography, and record what happened to slow-wave sleep, REM cycles, or wake-after-sleep-onset time? Not in the literature supplied here. Not in the databases those reviews searched. Not anywhere I could find, and I looked.

The 2025 lemon balm review, which shares citral as a bioactive, does list sleep among traditional uses. Traditional use is not the same as a controlled trial. It means people have been drinking it for centuries and nobody wrote down what it did. That is fine for a cup of tea. It is not the same evidentiary standard as the one the label implies when it says citral sleep support with a straight face and a twenty-dollar price tag.

What You Are Buying When You Buy a Lemongrass Sleep Supplement

If the question is does lemongrass help you sleep better, the answer the literature gives is: we know it does something to a neuron, we have not checked if that translates to a human closing their eyes at night. The dosage is unclear. The delivery method varies between inhaled vapor, topical oil, and encapsulated extract, and nobody has compared them. The duration is untested. Eight weeks is cited in some aromatherapy studies, which is exactly how long it takes to finish a bottle and forget to reorder. Convenient, that.

The 2012 cancer care review noted that aromatherapy showed no long-lasting effect, only short-term improvements up to eight weeks. It also reported minimal adverse effects from essential oils generally, with risks including skin irritation, allergic contact dermatitis, and phototoxicity from some oils under sunlight. Lemongrass oil applied topically can cause irritation in sensitive individuals, though it is generally recognized as safe when used appropriately. Which is to say: it probably will not hurt you. That is the ceiling.

What is not reported anywhere in these reviews: a human trial that measured lemongrass against placebo using objective sleep metrics. Not sleep diary self-report. Not a Likert scale rating of restfulness. Actual polysomnography, the kind that records brain waves and tells you how long you spent in each stage. The kind that costs money and produces answers the marketing department might not want.

The Marketing Wrote the Ending Before the Study Finished

The label says calming supplement. The research says citral modulates GABAergic activity in isolated neurons. Those are not the same sentence. One is a claim about your Tuesday night. The other is a description of what happened in a dish under a microscope. The distance between those two facts is where your money goes.

This is not to say lemongrass does nothing. It might. Plenty of things that bind GABA receptors in vitro go on to show effects in humans. The issue is that nobody checked, and the marketing proceeded as if they had. The bottle skips from the binding assay to the promise, and the only thing holding that structure up is the assumption that if it works on a receptor, it must work on a person. That assumption is doing a lot of unpaid labor.

That assumption is how you end up with a supplement aisle full of things that are technically true and commercially meaningless. Citral binds the receptor. Lemongrass contains citral. Therefore buy this capsule for your sleep. The step in the middle, where someone gives it to a hundred people for twelve weeks and measures whether they sleep deeper, is missing. Not delayed. Missing. Like the middle act of a three-act play where someone just taped the first page to the last and hoped you would not notice.

If you want lemongrass because you like the smell, or because it makes your evening tea ritual feel intentional, or because forty generations of traditional use carries weight for you, that is a defensible reason. If you want it because the label said sleep support and you thought that meant someone had measured your slow-wave sleep after taking it, the literature does not back that. It backs the receptor binding, the traditional use, the anxiolytic potential. The sleep architecture data does not exist yet. Maybe it will. Maybe it will not. Either way, the bottle is already on the shelf.

The marketing wrote the ending before the study finished. That is the part that ought to keep you up at night.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

  1. Bioactive Compounds, Medicinal Benefits, and Contemporary Extraction Methods for Lemon Balm (<i>Melissa officinalis</i>), Food science & nutrition (2025).
  2. The Effects of Essential Oils on the Nervous System: A Scoping Review, Molecules (Basel, Switzerland) (2023).
  3. Aromatherapy as an adjuvant treatment in cancer care--a descriptive systematic review, African journal of traditional, complementary, and alternative medicines : AJTCAM (2012).

Leave a comment

This site is protected by hCaptcha and the hCaptcha Privacy Policy and Terms of Service apply.